Registry of CLH intentions until outcome

Registry of CLH intentions until outcome

Registry of CLH intentions until outcome

The registry of classification and labelling (CLH) intentions until outcome lists the intentions and proposals received by ECHA for a new or revised harmonised classification and labelling of a substance. The proposals are submitted by Member State competent authorities, manufacturers, importers or downstream users.  

Interested parties can follow the progress of a proposal through the CLH process, from the notification of the intention to the adoption of the opinion of the Committee for Risk Assessment (RAC). The advance notice enables interested parties to plan and prepare for commenting later on.

Anyone with relevant information on the identity or hazard properties of a substance is encouraged to provide this information to the dossier submitter during the early stages of the process, or at the latest during the consultation.

Where an opinion has been adopted by RAC, the status is indicated as ‘Opinion Adopted’.

Note: The classification tables for those substances that have been reviewed are listed in the ‘Corrigenda to the RAC opinions’ document.

esfenvalerate (ISO); (αS)-α-cyano-3-phenoxybenzyl (2S)-2-(4-chlorophenyl)-3-methylbutyrate

EC / List no: 613-911-9 CAS no: 66230-04-4
CLP Annex VI Index number
608-058-00-4
Further substance information
Status
Opinion Adopted
Date of intention
02-nov.-2017
Expected date of submission
31-jul.-2018
Submitted for accordance check
24-jul.-2018
Final submission date
13-nov.-2018
Withdrawal date
Legal deadline for opinion adoption
14-maj-2020
Submitter
United Kingdom
Submitter's email
Harmonised classification at the time of the proposal
Acute Tox. 3*, H301
Acute Tox. 3*, H331
Skin Sens. 1, H317
Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Aquatic Chronic 1, M-factor=10 000
Specific concentration limits at the time of the proposal
Proposed harmonised classification by the dossier submitter
Acute Tox. 3, H301
Acute Tox. 2, H330
Skin Sens. 1, H317
STOT RE 2, H373
Aquatic Acute 1, H400
Aquatic Acute 1, M-factor=10 000
Aquatic Chronic 1, H410
Aquatic Chronic 1, M-factor=10 000
Proposed specific concentration limits by the dossier submitter
ATEoral = 88.5 mg/kg
ATEinhal = 0.48mg/L
Regulatory programme
Active substance in Plant Protection Products
Active substance in Biocidal Products
Remarks
Start of consultation
17-dec.-2018
Deadline for commenting
01-mar.-2019
Hazard classes open for commenting
Carcinogenicity
Mutagenicity
Acute Toxicity [inhalation]
Acute Toxicity [oral]
STOT SE
STOT RE
Skin Sensitisation
Hazards to the Aquatic Environment
CLH report
Annexes to the CLH report
Date of opinion
20-sep.-2019
RAC Opinion
Background document
RCOM (Comments received)
Attachments received during consultation (excluding journal articles)
Minority opinion(s)
Other annexes
ATP number and date
ATP17 - (11/03/2021), 17/12/2022
Link to ATP
Latest update
26-jul.-2022
First published
28-feb.-2018